Tina is 5 years old and presents to the emergency department with a 2-day history of coryza and cough with intermittent low-grade fever. She developed an audible wheeze and respiratory distress that was initially responsive to albuterol via a pressurized metered-dose inhaler and small-volume spacer. However, symptoms have recurred within 2 hours of albuterol administration. On exam, she is in visible respiratory distress with a respiratory rate of 40 breaths per minute and has accompanying accessory muscle use. Her oxygen saturations are 92% in room air, and on auscultation of her chest there is widespread polyphonic wheeze and equal air entry. She has an audible moist cough. After discharge she follows up with her primary care physician to review her asthma symptoms and medications.
Assessing and managing Tina's asthma symptoms can help her breathe easier, avoid visits to the hospital, and significantly improve her quality of life. Even for mild persistent disease, doing an assessment to formally classify asthma then using appropriate controller medication makes a difference.
|0001||Percentage of patients who were evaluated during at least one office visit for the frequency of daytime and nocturnal asthma symptoms||All patients:
|0047||Percentage of patients who were evaluated during at least one office visit for the frequency of daytime and nocturnal asthma symptoms||All patients:
||All patient with:
|NQF# Not Applicable||Percentage of patients identified as having persistent asthma during the measurement year and the year prior to the measurement year and who were dispensed a prescription for either an inhaled corticosteroid or acceptable alternative medication during the measurement year||All patients with medical record documentation of >>
1 written prescription for:
||Systematic sample of patients with:
Each of the Clinical Quality Measures has an NQF number, indicating that it has received endorsement from the National Quality Forum (NQF), a nonprofit organization with the mission to improve the quality of American healthcare. NQF uses a formal Consensus Development Process (CDP) to evaluate and endorse consensus standards, including performance measures. This process includes gathering input on performance measures from a wide variety of stakeholders including consumer organizations and health care providers.
Produced by Meaningful Use Quality Workgroup - February 14, 2013